Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal MSCs for CNS Injury
NCT03291366Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Jan 2017
- Primary completion
- Jan 2020
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in central nervous system injury (CNSI), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
central nervous system injury (CNSI)
Beyond the preview
Go deeper on NCT03291366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291366.